Harvard Bioscience Analyst Ratings
Harvard Bioscience Analyst Ratings
While ratings are subjective and will change, the latest Harvard Bioscience (HBIO) rating was a maintained with a price target of $7.00 to $5.00. The current price Harvard Bioscience (HBIO) is trading at is $2.42, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/09/2022 | 106.61% | Keybanc | $7 → $5 | Maintains | Overweight |
| 08/05/2022 | 189.26% | Keybanc | $10 → $7 | Maintains | Overweight |
| 11/10/2020 | 147.93% | Keybanc | → $6 | Initiates Coverage On | → Overweight |
| 02/27/2020 | 65.29% | Benchmark | $3.5 → $4 | Maintains | Speculative Buy |
| 日期 | 上/下行 | 分析師公司 | 价格目標變更 | 評級變更 | 上一頁/目前評分 |
|---|---|---|---|---|---|
| 11/09/2022 | 106.61% | 鑰匙班 | 7 美元 → 5 美元 | 維護 | 超重 |
| 2022 年 5 月 8 日 | 189.26% | 鑰匙班 | 十美元 → 7 美元 | 維護 | 超重 |
| 11/10/2020 | 147.93% | 鑰匙班 | → 6 美元 | 啟動覆蓋範圍 | → 超重 |
| 02/27/2020 | 65.29% | 基準 | 3 美元 → 4 美元 | 維護 | 投機性購買 |
Harvard Bioscience Questions & Answers
哈佛生物科學問題與答案
The latest price target for Harvard Bioscience (NASDAQ: HBIO) was reported by Keybanc on November 9, 2022. The analyst firm set a price target for $5.00 expecting HBIO to rise to within 12 months (a possible 106.61% upside). 2 analyst firms have reported ratings in the last year.
哈佛生物科學（納斯達克股票代碼：HBIO）的最新價格目標已於 2022 年 11 月 9 日報導。該分析師公司將目標價格設定為 5.00 美元，預計 HBIO 將在 12 個月內上升（可能是 106.61％ 的上漲空間）。2 家分析師公司在去年報告了評級。
The latest analyst rating for Harvard Bioscience (NASDAQ: HBIO) was provided by Keybanc, and Harvard Bioscience maintained their overweight rating.
哈佛生物科學（NASDAQ：HBIO）的最新分析師評級由 Keybanc 提供，哈佛生物科學保持其超重評級。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Harvard Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Harvard Bioscience was filed on November 9, 2022 so you should expect the next rating to be made available sometime around November 9, 2023.
分析師進行了廣泛的研究，其中包括通過公共財務報表，與哈佛生物科學的高管和客戶交談以及收益電話會議後到達股票評級。大多數分析師每三個月這樣做一次，因此您應該每年每家公司獲得 4 個評級。哈佛生物科學的最後評分於 2022 年 11 月 9 日提交，因此您應該期望下一個評分將在 2023 年 11 月 9 日左右的某個時間提供。
While ratings are subjective and will change, the latest Harvard Bioscience (HBIO) rating was a maintained with a price target of $7.00 to $5.00. The current price Harvard Bioscience (HBIO) is trading at is $2.42, which is out of the analyst's predicted range.
雖然評分是主觀的並且會發生變化，但最新的哈佛生物科學（HBIO）評級維持，目標價格為 7.00 美元至 5.00 美元。目前的價格哈佛生物科學（HBIO）的交易價格為 2.42 美元，超出了分析師的預測範圍。
譯文內容由第三人軟體翻譯。
